APP and Alzheimer disease: Additionally, PU-AD did not affect basal synaptic transmission, as shown by the input-output relationship in both WT and APP NL-F mice (Supplementary Fig. 10a,11a), confirming that PU-AD specifically targets pathological disruptions caused by epichaperomes without disturbing normal synaptic functions.